Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 232,175,161 papers from all fields of science
Search
Sign In
Create Free Account
Neutropenia
Known as:
Neutropenia, unspecified
, Neutropenia [Disease/Finding]
, NEUTROPHILS DECREASED
Expand
A decrease in the number of NEUTROPHILS found in the blood.
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
50 relations
2 ML Methotrexate 25 MG/ML Injection
24 HR Ciprofloxacin 500 MG Extended Release Oral Tablet
Amphotericin 100mg powder for infusion solution vial
Amphotericin B
Expand
Broader (1)
Leukopenia
Narrower (3)
Lichtenstein syndrome
Neutropenia, Severe Congenital, Autosomal Dominant 2
Neutropenia, Severe Congenital, X-Linked
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2005
Highly Cited
2005
Safety of prolonged therapy with bortezomib in relapsed or refractory multiple myeloma
J. Berenson
,
S. Jagannath
,
+14 authors
K. Anderson
Cancer
2005
Corpus ID: 34947728
Bortezomib, a first‐in‐class proteasome inhibitor, is active with manageable toxicities in relapsed and/or refractory myeloma.
Highly Cited
2001
Highly Cited
2001
Trichosporon species infection in bone marrow transplanted patients.
M. L. Moretti-Branchini
,
K. Fukushima
,
+5 authors
M. Miyaji
Diagnostic microbiology and infectious disease
2001
Corpus ID: 43208856
Highly Cited
2001
Highly Cited
2001
A phase II study of pemetrexed disodium (LY231514) in patients with locally recurrent or metastatic breast cancer.
D. Miles
,
I. Smith
,
R. Coleman
,
A. Calvert
,
M. Lind
European Journal of Cancer
2001
Corpus ID: 9390405
Highly Cited
1998
Highly Cited
1998
Docetaxel (Taxotere) plus cisplatin: an active and well-tolerated combination in patients with advanced non-small cell lung cancer.
T. Chevalier
,
A. Monnier
,
+6 authors
J. Bérille
European Journal of Cancer
1998
Corpus ID: 31423957
Review
1995
Review
1995
Docetaxel (Taxotere), a review of preclinical and clinical experience. Part II: Clinical experience.
A. Oosterom
,
Dirk Schriivers
1995
Corpus ID: 196481823
Docetaxel, a promising inhibitor of microtubule depolymerization has shown significant anti-cancer activity during phase I and…
Expand
Highly Cited
1985
Highly Cited
1985
Phase I pharmacologic study of a new Vinca alkaloid: navelbine.
G. Mathé
,
P. Reizenstein
Cancer Letters
1985
Corpus ID: 23853910
Highly Cited
1980
Highly Cited
1980
USE OF MODIFIED SUBCUTANEOUS RIGHT-ATRIAL CATHETER FOR VENOUS ACCESS IN LEUKÆMIC PATIENTS
H. Blacklock
,
R. Hill
,
A. G. Clarke
,
M. Pillai
,
J. Matthews
,
J. Wade
The Lancet
1980
Corpus ID: 7166523
Highly Cited
1970
Highly Cited
1970
Liver in Felty's Syndrome
L. Blendis
,
Ansell Id
,
K. L. Jones
,
E. Hamilton
,
Roger Williams
British medical journal
1970
Corpus ID: 1872404
Liver function and histology, together with the haematological changes, were investigated in 12 patients with Felty's syndrome…
Expand
Highly Cited
1969
Highly Cited
1969
Observations on the coexistence of methylmalonic acidemia and glycinemia.
G. Morrow
,
L. Barness
,
V. Auerbach
,
A. Digeorge
,
T. Ando
,
W. Nyhan
Jornal de Pediatria
1969
Corpus ID: 40944748
Highly Cited
1960
Highly Cited
1960
Comparative trial of isoniazid in combination with thiacetazone or a substituted diphenylthiourea (SU1906) or PAS in the treatment of acute pulmonary tuberculosis in east africans
B. Kinsley
,
Pepys
,
Sutherland
1960
Corpus ID: 208371662
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE